A VIRTUAL Three-month Intervention Study of the Effects of a Smartphone Application (HippoCamera) on Memory in Teens and Young Adults With Down Syndrome

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age15-35
SponsorBoston College

About this trial

Down syndrome is a chromosomal abnormality associated with significant deficits across multiple cognitive domains, including a disproportionate deficit in hippocampally-dependent memory. In other words, individuals with Down syndrome may have a particular difficulty remembering specific details from past events. One way this manifests itself is in overgeneral autobiographical memory, or a tendency to remember the general gist of an event or cluster of events, rather than a single, isolated event. This overgeneral memory makes it difficult for individuals with Down syndrome to access their past, can interfere with attempts to becoming more independent, and increases anxiety and depression.

In the current VIRTUAL study, the investigators test whether a new digital memory prosthetic-HippoCamera-can enhance specific autobiographical memory in individuals with Down syndrome. In HippoCamera, users are asked to record and replay events from their daily lives. This replay is curated by a research-based algorithm in HippoCamera that optimizes consolidation of these events over time and has been shown to enhance memory specificity in other populations with memory impairments, particularly those that stem from hippocampal disfunction. It is, therefore, likely that similar enhancements in autobiographical memory specificity will be identified in individuals with Down syndrome, highlighting the benefits of this applications in this population.

Eligibility criteria

Qualifiers

Diagnosis of Down syndrome

Daily access to a smart phone

The ability to create and replay memories using HippoCamera with limited support from a guardian

Informed consent obtained from parent or guardian (or participant, if legally independent)

Disqualifiers

Autism

Non-native speaker of English (acquired after the age of 5)

Trial design

Treatments tested in this trial

  • Memory replay

Treatment groups

40 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Boston College

Lead sponsor

Massachusetts General Hospital

Collaborator

University of Colorado, Denver

Collaborator